France Neurosurgical Instruments Market Size, Share, By Product (Cutting and Dissecting Instruments, Tissue Handling and Manipulation Instruments, Access and Insertion Instruments, and Others), By End Use (Hospitals and Outpatient Facilities), and France Neurosurgical Instruments Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Dec 2025
REPORT ID SI16845
PAGES 167
REPORT FORMAT PathSoft

  • France Neurosurgical Instruments Market Size 2024: USD 61.2 Mn
  • France Neurosurgical Instruments Market Size 2035:  USD 174.7 Mn
  • France Neurosurgical Instruments Market CAGR 2024: 10.01%
  • France Neurosurgical Instruments Market Segments: Product, Application, and Distribution Channel

France Neurosurgical Instruments Market

Get more details on this report -

Request Free Sample PDF

The France Neurosurgical Instruments Market Size refers to the segment of the medical devices industry that is focused on the tools and equipment that are used in the diagnosis, surgical treatment, and management of neurological disorders that involve the brain, spine, and peripheral nerves. Such instruments comprise the likes of medical forceps, surgical scissors, surgical drills, retractors, suction devices, and high-tech equipment that is used in minimally invasive and microsurgical neurosurgical procedures. The market is spread across the hospitals and specialized neurology centers in France.

 

The neurosurgical instruments market in France is largely governed by the rise in the number of neurological disorders that need surgical intervention. As an illustration, Parkinson's disease is reported to affect approximately 200,000 people in France, with the number of cases going up as the population is getting older, thus creating a continuous demand for neurosurgical care and related instruments. Besides that, epilepsy impacts more than 600,000 individuals, out of which a significant number may require surgical evaluation and intervention at an advanced level, thus underscoring the clinical need for accurate neurosurgical instruments.

 

The market has the potential to tap into new sources of revenue such as the widespread adoption of minimally invasive neurosurgical procedures, integration of advanced imaging and robotic assistance, and increasing demand for instruments that facilitate brain and spine surgeries that are complex to an extent. The research support is strengthened by government-backed initiatives like the France 2030 digital health program, which is investing €60 million in digital health and biomedical innovation, thus enabling the development of advanced diagnostics and surgical technologies that are relevant to neuroscience. Moreover, local research initiatives such as DIM C BRAINS provide funds for neuroscience and cognitive science events and collaborations, thereby enhancing not only the research ecosystem in France but also the long-term implementation of innovative neurosurgical instruments.

 

France Neurosurgical Instruments Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 61.2 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :10.01%
2035 Value Projection:USD 174.7 Million
Historical Data for:2020-2023
No. of Pages:167
Tables, Charts & Figures:107
Segments covered:By Product, By End Use
Companies covered::Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Karl Storz SE & Co. KG, Johnson & Johnson, NeuroPace, Inc., Penumbra, Inc., and others key players
Pitfalls & Challenges:COVID-19 Empact,Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Market Dynamics of the France Neurosurgical Instruments Market:

The France neurosurgical instruments market is driven by the increasing incidence of neurological disorders such as Parkinson's disease, epilepsy, brain tumors, and stroke, as well as a rapidly aging population that is driving the surgical case volumes. Moreover, the expanding use of minimally invasive and image-guided neurosurgical procedures, ongoing technological innovations (robotics, navigation systems), and the provision of generous government support for neuroscience research and hospital infrastructure are some of the factors that are contributing to the market growth.

 

The market for neurosurgical instruments in France is being restrained by the expensive advanced neurosurgical equipment that is not affordable for small hospitals, thereby limiting the adoption of such equipment in them, as well as by strict regulations and requirements for approvals that can delay the release of new products. Besides these, the lack of enough highly skilled neurosurgeons, coupled with long training periods and limitations on reimbursements for complicated procedures, can slow down the growth of the market as a whole.

 

Future opportunities and developments in the France neurosurgical instruments market include the growing adoption of robot-assisted and minimally invasive neurosurgical techniques, which enhance precision and reduce patient recovery times. Advances in image-guided surgery, augmented reality, and AI-assisted decision support are expected to expand clinical applications. Additionally, increased investment in biomedical research, digital health innovation, and integrated surgical systems, supported by government initiatives, will drive the development and adoption of next-generation neurosurgical instruments across France.

 

Market Segmentation

The France Neurosurgical Instruments Market share is classified into product and end use.

By Product:

The France neurosurgical instruments market is divided by product into cutting and dissecting instruments, tissue handling and manipulation instruments, access and insertion instruments, and others. Among these, the tissue handling and manipulation instruments segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The tissue handling and manipulation instruments segment dominates because these tools are essential in nearly all neurosurgical procedures for precise grasping, retraction, and stabilization of delicate neural tissues. Their frequent use in both open and minimally invasive surgeries, along with rising procedure volumes and technological improvements, supports strong adoption.

 

By End Use:

The France neurosurgical instruments market is divided by end use into hospitals and outpatient facilities. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The hospital segment’s dominance is due to the high volume of complex neurosurgical procedures performed in hospital settings, the availability of advanced operating rooms and skilled neurosurgeons, and better access to high-cost neurosurgical technologies supported by public healthcare funding.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the France neurosurgical instruments market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Key Companies in France Neurosurgical Instruments Market:

  • Medtronic plc
  • Boston Scientific Corporation
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Holdings Corporation
  • Karl Storz SE & Co. KG
  • Johnson & Johnson
  • NeuroPace, Inc.
  • Penumbra, Inc.
  • Others

 

Recent Developments in France Neurosurgical Instruments Market:

  • In May 2025, French medtech company RebrAIn secured MDR CE certification for its OptimMRI AI-powered surgical planning platform, enabling precision neurosurgical targeting in deep brain stimulation and lesioning procedures across European markets.

 

  • In September 2025, Marginum’s HIVEN intraoperative aspirate tissue monitoring device received CE Mark certification, enabling clinical use in fluorescence-guided neurosurgery across Europe, including France, to help surgeons better detect tumor margins during brain tumor resections.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Spherical insights has segmented the France Neurosurgical Instruments market based on the below-mentioned segments:

 

France Neurosurgical Instruments Market, By Product 

  • Cutting and Dissecting Instruments
  • Tissue Handling and Manipulation Instruments
  • Access and Insertion Instruments
  • Others

 

France Neurosurgical Instruments Market, By End Use 

  • Hospitals
  • Outpatient Facilities

Frequently Asked Questions (FAQ)

  • 1. What is the France neurosurgical instruments market size in 2024?
    The France neurosurgical instruments market size was estimated at USD 61.2 million in 2024.
  • 2. What is the projected market size of the France neurosurgical instruments market by 2035?
    The France neurosurgical instruments market size is expected to reach USD 174.7 million by 2035.
  • 3. What is the CAGR of the France neurosurgical instruments market?
    The France neurosurgical instruments market size is expected to grow at a CAGR of around 10.01% from 2024 to 2035.
  • 4. What are the key growth drivers of the France neurosurgical instruments market?
    The increasing incidence of neurological disorders such as Parkinson's disease, epilepsy, brain tumors, and stroke, as well as a rapidly aging population, ongoing technological innovations, and government support for neuroscience research and hospital infrastructure.
  • 5. Which product segment dominated the market in 2024?
    The tissue handling and manipulation instruments segment dominated the market in 2024.
  • 6. What segments are covered in the France neurosurgical instruments market report?
    The France neurosurgical instruments market is segmented on the basis of product and end use.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies